Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Garey

Showing results (61-70 of 300) with videos related to

Pageof 30
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2025
Association between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes among Hospitalized Adult Patients with Candidemia Who Received Empiric Treatment with an Echinocandin Across United States HospitalsThomas P Lodise, Kevin W Garey, Jalal A Aram, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 26, 2013
Crofelemer, a novel antisecretory agent approved for the treatment of HIV-associated diarrheaQ M Yeo, R Crutchley, J Cottreau, et al.
Pharmacoepidemiology and Drug Safety|October 23, 2020
Antibiotic utilization within 18 community hospitals in the United States: A 5-year analysisAbrar K Thabit, Katherine M Shea, Oscar E Guzman, et al.
American Journal of Pharmaceutical Education|June 24, 2014
Education, training, and academic experience of newly hired, first-time pharmacy faculty membersMatthew A Wanat, Marc L Fleming, Julianna M Fernandez, et al.
The Annals of Pharmacotherapy|April 24, 2008
Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrheaKevin W Garey, Miguel Salazar, Dhara Shah, et al.
Open Forum Infectious Diseases|January 12, 2024
Healthcare Resource Utilization and Discharge Readiness in Adult Hospitalized Patients With Candidemia or Invasive Candidiasis Who Received an Echinocandin: An Analysis of United States HospitalsThomas P Lodise, Kevin W Garey, Jalal A Aram, et al.
Journal of Pharmacy Practice|October 15, 2014
Assessment of Antimicrobial Stewardship Activities in a Large Metropolitan AreaDavid M Jacobs, Kristi Kuper, Edward Septimus, et al.
Pharmacotherapy|June 13, 2001
Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecium [correction of faecalis] ventriculitisK W Garey, E Tesoro, V Muggia, et al.
Anaerobe|February 19, 2009
WITHDRAWN: In vitro activity of rifaximin and rifampin against clinical isolates of clostridium difficile in houston, texasZhi-Dong Jiang, Herbert L Dupont, Mark La Rocco, et al.
Journal of Chemotherapy (Florence, Italy)|November 26, 2008
Killing activity of rifampin with piperacillin therapy against adherent cells of Pseumodomas aeruginosaK W Garey, M V Martorell, Q P Vo, et al.
Pageof 30

Showing results (61-70 of 300) with videos related to

Sort By:
Pageof 30
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2025
Association between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes among Hospitalized Adult Patients with Candidemia Who Received Empiric Treatment with an Echinocandin Across United States HospitalsThomas P Lodise, Kevin W Garey, Jalal A Aram, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 26, 2013
Crofelemer, a novel antisecretory agent approved for the treatment of HIV-associated diarrheaQ M Yeo, R Crutchley, J Cottreau, et al.
Pharmacoepidemiology and Drug Safety|October 23, 2020
Antibiotic utilization within 18 community hospitals in the United States: A 5-year analysisAbrar K Thabit, Katherine M Shea, Oscar E Guzman, et al.
American Journal of Pharmaceutical Education|June 24, 2014
Education, training, and academic experience of newly hired, first-time pharmacy faculty membersMatthew A Wanat, Marc L Fleming, Julianna M Fernandez, et al.
The Annals of Pharmacotherapy|April 24, 2008
Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrheaKevin W Garey, Miguel Salazar, Dhara Shah, et al.
Open Forum Infectious Diseases|January 12, 2024
Healthcare Resource Utilization and Discharge Readiness in Adult Hospitalized Patients With Candidemia or Invasive Candidiasis Who Received an Echinocandin: An Analysis of United States HospitalsThomas P Lodise, Kevin W Garey, Jalal A Aram, et al.
Journal of Pharmacy Practice|October 15, 2014
Assessment of Antimicrobial Stewardship Activities in a Large Metropolitan AreaDavid M Jacobs, Kristi Kuper, Edward Septimus, et al.
Pharmacotherapy|June 13, 2001
Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecium [correction of faecalis] ventriculitisK W Garey, E Tesoro, V Muggia, et al.
Anaerobe|February 19, 2009
WITHDRAWN: In vitro activity of rifaximin and rifampin against clinical isolates of clostridium difficile in houston, texasZhi-Dong Jiang, Herbert L Dupont, Mark La Rocco, et al.
Journal of Chemotherapy (Florence, Italy)|November 26, 2008
Killing activity of rifampin with piperacillin therapy against adherent cells of Pseumodomas aeruginosaK W Garey, M V Martorell, Q P Vo, et al.
Pageof 30